Order results by:
| Issue | Title | |
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... , as well as safety of statin therapy were studied in the groups. Results. 25.6, 70.7 and 52% of patients ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... group II (n=32) did not take statins. The duration of follow-up was 4 years. The evolution of the AF ..." | ||
| Vol 10, No 6 (2014) | DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) | Abstract similar documents |
| A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov | ||
| "... group (n=1642). Results. The group of patients with severe hypercholesterolemia consisted of 561 (44 ..." | ||
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| "... The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... ) were achieved in 10 (71.4%) patients in each group. After 8 weeks of therapy with generic and original ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..." | ||
| Vol 3, No 1 (2007) | MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY | Abstract similar documents |
| An. A. Alexandrov, I. I. Tchukaeva | ||
| "... has been identified in different groups of patients including syndrome X, diabetes mellitus 2 type ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... proatherogenic blood profile was observed in both groups. The patients of MTX group more frequently took statins ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... were randomized from first 24-hour of admission to either atorvastatin 80 mg daily (group 1 ..." | ||
| Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
| N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
| "... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... Aim. To identify the main problems of statin therapy in patients with high and very high ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... groups. Group 1 had a titration regimen of statins in accordance with current recommendations (group 1A ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents ..." | ||
| Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
| Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
| "... in the intervention group continued taking statins versus 29 (43%) respondents in the control group (p<0.05), 3 months ..." | ||
| Vol 9, No 4 (2013) | STATINS AND THE RISK OF DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina | ||
| "... Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 8, No 3 (2012) | STATINS AND MYOPATHY: MOLECULAR MECHANISMS | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova, O. N. Korneeva | ||
| "... The safety of statin therapy is considered. In particular the reasons of a complication ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... into 2 groups. Group 1 had a titration regimen of statins in accordance with current recommendations ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special ..." | ||
| Vol 9, No 2 (2013) | STATIN SAFETY REVISITED DATA | Abstract similar documents |
| O. M. Drapkina | ||
| "... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE | Abstract similar documents |
| A. I. Chesnikova, V. A. Safronenko, A. V. Hripun | ||
| "... on the statin therapy compliance during 5 years after MI: group 1 — patients with high compliance, group 2 ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... and paroxysmal AF were included in the study. Patients were divided into two groups – control group (basic ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... ). The control group was not prescribed statins before the intervention. In both groups, further statin therapy ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... pharmacoepidemiology study. Results. Prescription rate significantly increased for three of four prophylactic groups ..." | ||
| Vol 13, No 2 (2017) | STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | Abstract similar documents |
| I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov | ||
| "... interatomic distances between the atoms of statins and micelles. Material and methods. Nuclear magnetic ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The main indications to statins and principles of statin usage on the basis of International ..." | ||
| Vol 5, No 6 (2009) | STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? | Abstract similar documents |
| I. N. Grigorieva, Y. M. Pozdnyakov | ||
| "... ), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic ..." | ||
| Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
| V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
| "... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..." | ||
| Vol 4, No 4 (2008) | LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov | ||
| "... groups. Patients of the 1st group (n=44) received lovastatin (20-60 mg daily) in addition ..." | ||
| Vol 12, No 5 (2016) | Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis | Abstract similar documents |
| M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov | ||
| "... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..." | ||
| Vol 11, No 4 (2015) | TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE | Abstract similar documents |
| V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova | ||
| "... cholesterol >9 mmol/l) the frequency of statins prescription in 2009-2012 was 70%. In 28.9% of the patients ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..." | ||
| Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
| A. N. Meshkov | ||
| "... of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled ..." | ||
| Vol 14, No 4 (2018) | Statin Therapy and Cognitive Impairment: Benefit or Harm? | Abstract similar documents |
| O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova | ||
| "... Statins are now widely used drugs for the treatment of dyslipidemia, effective drugs for lowering ..." | ||
| Vol 2, No 2 (2006) | PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The article underlines necessity of statins treatment for patients with high risk of cardio ..." | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... , as well as drugs of other pharmacological groups, the use of statins from earlier ages, the practical ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 9, No 3 (2013) | INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina | ||
| "... Aim. To assess the risk factors of statin-associated muscle damage in patient with ischemic heart ..." | ||
| Vol 10, No 3 (2014) | THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW | Abstract similar documents |
| D. A. Napalkov | ||
| "... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..." | ||
| Vol 11, No 6 (2015) | Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? | Abstract similar documents |
| I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov | ||
| "... A hypothesis that possible pleiotropic features of different statins could be explained ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..." | ||
| Vol 1, No 3 (2005) | RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... . The perspectives of treatments with statins in RA are given. Results of clinical trials on statin effects ..." | ||
| Vol 14, No 6 (2018) | Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues | Abstract PDF (Eng) similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan | ||
| "... on a low number of patients taking statins, and even less – reaching recommended target cholesterol levels ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... lipid-lowering therapy and can be considered as a predictor of resistance to statins. ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... , adherent and non-adherent to statins, revealed the economic advantage of statins in groups of adherent ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the ACE inhibitors, marked ..." | ||
| Vol 10, No 4 (2014) | STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN | Abstract similar documents |
| N. G. Gogolashvili | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... for statins use. Material and methods. Patients (n=262, age 60.1±8.9 years) took statins for secondary ..." | ||
| Vol 18, No 6 (2022) | The Pathogenetic Basis of the Action of Bempedoic Acid | Abstract similar documents |
| A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin | ||
| "... metabolic pathway as statins, but at an earlier stage. According to this, it is possible that medications ..." | ||
| Vol 5, No 2 (2009) | OBSERVATIONAL TRAILS IN LIPIDOLOGY | Abstract similar documents |
| S. A. Shalnova | ||
| "... and observational trails are presented. The trail data on statins efficacy and safety are held up as a model. ..." | ||
| Vol 11, No 1 (2015) | MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova | ||
| "... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... was significantly above the target and varied from 5.82 to 6.10 mmol/L. At that, statins had not been prescribed ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 9, No 6 (2013) | APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY | Abstract similar documents |
| D. A. Sychev, G. N. Shuev, A. B. Prokofiev | ||
| "... polipeptide) in the development of statin induced myopathy is considered. Possible tactics of statin dose ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... in patients with CVD risk factors, of course, are statins. The results of multi-center studies showing ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... function, ability to reduce the blood level of C-reactive protein are important in the statins mode ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..." | ||
| Vol 13, No 4 (2017) | HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? | Abstract similar documents |
| I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova | ||
| "... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted ..." | ||
| Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
| D. A. Napalkov, A. V. Zhilenko | ||
| "... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... statin therapy was recommended for 32% of patients, and combined lipid-lowering therapy – for 14 ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| "... Aim. To study the opinion of doctors about the possibility of statins prescription to patients ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... schemes and the preferred doses of statins and antiplatelet agents depending on the localization ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..." | ||
| Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
| I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
| "... (ACE inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... антитромбоцитарных свойств статинов, их связь со стимуляцией продукции оксида азота, мощного эндогенного ..." | ||
| Vol 1, No 2 (2005) | STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY | Abstract similar documents |
| Y. A. Karpov | ||
| "... , aswell as problems of statin treatment safety. The choice of the drug must be based on clinical research ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... lipoproteins in men and women with coronary atherosclerosis treated with statins depending on low density ..." | ||
| Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
| N. V. Perova | ||
| "... Comparative dose-dependent ability of different statins to lower serum low-density lipoproteins ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| "... Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered ..." | ||
| Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
| O. V. Andropova, V. N. Anokhin | ||
| Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... Aim. To evaluate the frequency of prescription, efficacy and patients adherence to statin therapy ..." | ||
| Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, beta-blockers ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 20, No 3 (2024) | NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management | Abstract similar documents |
| P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina | ||
| "... with cardiovascular outcomes. New clinically relevant pleotorpic effects of statins, sodium-glucose cotransporter-2 ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... for taking statins and β-adrenoblockers in the group of elderly patients. ..." | ||
| Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
| A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
| "... in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid ..." | ||
| Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina, B. B. Gegenava | ||
| Vol 7, No 1 (2011) | EXPERT CONCLUSION OF THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION, RUSSIAN NATIONAL SOCIETY OF ATHEROSCLEROSIS, RUSSIAN SOCIETY OF CARDIOSOMATIC REHABILITATION AND SECONDARY PREVENTION ON STATIN THERAPY OPTIMIZATION IN CLINICAL PRACTICE | similar documents |
| Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
| M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
| "... ) was studied based on the results of a questionnaire. Results. Monotherapy with statins was prescribed in 55 ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... metabolism and biochemical safety of statin use were analyzed. The duration of observation of results ..." | ||
| Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
| Yu. A. Karpov | ||
| "... the event. The use of high-intensity statin therapy in this group of patients does not always lead ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... prescribed group of lipid-lowering drugs was statins, while combined treatment or monotherapy with other ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed ..." | ||
| Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
| N. V. Perova, V. A. Metelskaya | ||
| "... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... of cardiovascular diseases in patients ≥80 years of age who are the most quickly growing group of population ..." | ||
| Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
| Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
| "... specific pharmacological groups of medications for primary and secondary cardiovascular diseases prevention ..." | ||
| Vol 8, No 6 (2012) | THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS | Abstract similar documents |
| S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina | ||
| "... reference AMI only a small number of the patients received the main drug groups (antiplatelet agents, β ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... drugs, while for some groups of drugs this decrease reached statistically significant differences ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... ), statins, sodium-glucose transporter type 2 inhibitors (SGLT-2i) and oral anticoagulants (OAC). Results ..." | ||
| Vol 18, No 6 (2022) | Adherence to Visits to Medical Institutions and Quality of Therapy after Acute Coronary Syndrome (according to the LIS Registry 3) | Abstract similar documents |
| N. P. Zolotareva, A. V. Zagrebelny, M. L. Ginzburg, S. Yu. Martsevich, O. M. Drapkina | ||
| "... -blockers – 4 times (OR 4.103, p<0.001), statins – 4.5 times (OR 4.450, p<0.001), in relation to the group ..." | ||
| Vol 4, No 2 (2008) | RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. I. Chesnikova, I. N. Koshenskaja, V. P. Terentyev, N. N. Mozhaeva, I. V. Bedareva, L. A. Lavrik, T. V. Zhertovsky | ||
| "... therapy with aspirin, statin and ß-blocker. Patients of the 2nd group received the same therapy as well ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... .001). Patients in group 2 were more likely to receive statins (p<0.001), β-blockers (p<0.001), angiotensin ..." | ||
| Vol 14, No 1 (2018) | OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY | Abstract similar documents |
| N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich | ||
| "... , according to both registries, refers to drugs from the statin group. ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... in patients of different age groups, belonging to the category of high and extremely high cardiovascular risk ..." | ||
| 1 - 100 of 829 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
